Uranium–uranium dating
U, with a half-life of about 4.5 billion years, decays to U through emission of an alpha particle to thorium-234 (Th), which is comparatively unstable with a half-life of just 24 days. Th then decays through beta particle emission to protactinium-234 (Pa)). This decays with a half-life of 6.7 hours, again through emission of a beta particle, to U. This isotope has a half-life of about 245,000 years. The next decay product, thorium-230 (Th), has a half-life of about 75,000 years and is used in the uranium-thorium technique. Although analytically simpler, in practice U/U requires knowledge of the ratio at the time the material under study was formed and is generally used only for samples older than the ca. 450,000 year upper limit of the Th/U technique. For those materials (principally marine carbonates) for which these conditions apply, it remains a superior technique.
Actinium
A soft, silvery-white radioactive metal, actinium reacts rapidly with oxygen and moisture in air forming a white coating of actinium oxide that prevents further oxidation. As with most lanthanides and many actinides, actinium assumes oxidation state +3 in nearly all its chemical compounds. Actinium is found only in traces in uranium and thorium ores as the isotope Ac, which decays with a half-life of 21.772 years, predominantly emitting beta and sometimes alpha particles, and Ac, which is beta active with a half-life of 6.15 hours. One tonne of natural uranium in ore contains about 0.2 milligrams of actinium-227, and one tonne of thorium contains about 5 nanograms of actinium-228. The close similarity of physical and chemical properties of actinium and lanthanum makes separation of actinium from the ore impractical. Instead, the element is prepared, in milligram amounts, by the neutron irradiation of in a nuclear reactor. Owing to its scarcity, high price and radioactivity, actinium has no significant industrial use. Its current applications include a neutron source and an agent for radiation therapy targeting cancer cells in the body and killing them.